AZN vs GSBD · P/E 28, $288.38B cap vs P/E 14, $997.4M cap
AstraZeneca PLC (AZN) versus Goldman Sachs BDC Inc (GSBD) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Goldman Sachs BDC Inc (GSBD) is a asset management company listed on US.
AZN does not have a complete income-statement cache yet.
GSBD does not have a complete income-statement cache yet.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GSBD currently screens at market cap $997.4M and trailing P/E 13.8.
Not investment advice. Open the AZN and GSBD stock pages for the full models.
Not investment advice.